Clinical Trials
2 trialsNCT03724747 2024-11-08
Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer
Bayer
Phase 1 Completed
NCT04516161 2022-03-31
EPIX
Bayer
Completed